The Exercise Paradox: Lousy for Losing Weight, Your Best Bet for Keeping It Off

I have spent a lot of gym hours doing arithmetic that turns out to be fiction. Forty minutes on the bike, the console promising four hundred calories back, and me quietly editing the day’s food ledger as if that number meant anything. It mostly doesn’t. And the way it fails is stranger, and more useful, than the failure itself.

That is roughly the case Rachel Woods, a physiologist at the University of Lincoln, laid out this week in The Conversation. The headline comes from a study of more than 1,100 people: physical activity had little effect on how much weight anyone actually lost, but higher activity after the weight came off was strongly linked to keeping it off. Same behavior, two completely different jobs, and we have spent years selling it for the wrong one. Hold onto that, because the one thing that actually holds weight down long-term happens to be the one thing no company can bottle, patent, or bill you for monthly.

The disappointing half is old news. You cannot outrun a bad diet; everyone has heard that by now. What I keep circling is why the treadmill is so bad at melting fat in the first place, because the answer says something odd about how the body budgets energy.

Wait, if I burn an extra three hundred calories running, where do they go? The intuitive model says they come straight off the top, a clean subtraction. The body does not play that way. Under what physiologist Herman Pontzer calls the constrained energy model, your daily energy expenditure behaves less like a tab you can run up and more like a budget the body defends. Push activity up, and it quietly economizes elsewhere, trimming the restless fidgeting and dialing down other background processes to stay near its set point. Pontzer’s fieldwork with the Hadza, who are far more active than the average office worker, found they burn roughly the same number of daily calories as sedentary Westerners. The body is not a furnace you can simply stoke. It is a thermostat, and it is stubborn.

Woods stacks two more compensators on top. Exercise can crank appetite, so the deficit you earned on the bike gets quietly refilled at dinner. And over weeks the same workout gets metabolically cheaper as the body grows efficient at it. Three quiet mechanisms, all pushing the same way: the scale barely moves.

So why does the exact same activity become the thing that holds maintenance together? When you lose weight, you do not only shed fat. You lose muscle, and less muscle means a lower resting burn, which is the trapdoor that drops people back into regain. Exercise, especially resistance training, preserves and can even rebuild that muscle, so the metabolic floor holds. It also steadies appetite and blood sugar, so the cravings that ambush a maintainer land softer. None of that shows up as a dramatic number on weigh-in day. All of it shows up a year later, in whether the weight stayed gone.

The best real-world backing is observational, and I want to be upfront about that. The National Weight Control Registry has tracked thousands of people who lost significant weight and kept it off, and its members average around 2,600 calories a week in activity, roughly 60 to 90 minutes a day, most days. That is an association, not proof the movement caused the maintenance. But it lines up with the physiology, and it lines up with the 1,100-person data, and when the registry, the mechanism, and the study all point the same direction, I stop calling it coincidence.

Now set that beside the drug that has swallowed the entire weight conversation. GLP-1 medications like semaglutide do the one thing exercise cannot: fast, large, unambiguous weight loss. In the STEP 1 trial, participants lost about 15 percent of their body weight. Then came the extension nobody puts in the ads: a year after people stopped the shots, they had regained about two-thirds of what they lost, and their blood-pressure and metabolic gains drifted back toward the start. The drug is renting you a lower weight; it is not a purchase. And a large share of what it takes off is lean tissue, not fat. In STEP 1’s body-composition data, about 40 percent of the weight lost was lean mass, so the very muscle you would want defending you against regain is part of what the injection quietly removes.

That is the part the drug ads leave out. The intervention that actually holds the line is movement, and no one can bottle it, patent it, or bill you monthly for it, so it gets undersold. You will see a hundred ads for the shot that produces the before-and-after photo and almost none for the boring, unglamorous hour of activity that keeps the after from sliding back. GLP-1 drugs are a useful tool for a lot of people. But a tool that stops working the moment you set it down is not a plan, and pretending otherwise is how millions of people end up cycling their weight, and their money, on repeat.

I came in half-expecting another “exercise doesn’t work, don’t bother” story, the kind that hands people permission to stay on the couch. It is the opposite. Exercise works; we just had the timing wrong. It is lousy at the sprint and quietly excellent at the marathon. So here is where I have landed for my own gym hours. I have stopped treating a workout as a withdrawal from some calorie account, because that ledger was always fiction; I do it now to protect muscle and hold a line, not to melt anything off. And if I were ever losing a lot of weight, on a diet or on one of these drugs, I would build the movement habit while the weight was coming off, not after, so the thing that keeps it gone is already in place when the easy part ends. That is the one I would bank on.

Sources

1. The Conversation – Rachel Woods, “The exercise paradox: why workouts aren’t great for weight loss but useful for maintaining a healthy body weight” (2026)
2. Frontiers in Nutrition – van Baak et al., “Physical Activity, Weight Loss, and Weight Maintenance in the DiOGenes Multicenter Trial” (2021)
3. Diabetes, Obesity and Metabolism – Wilding et al., “Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension” (2022)
4. Diabetes, Obesity and Metabolism – Neeland et al., “Changes in lean body mass with GLP-1-based therapies and mitigation strategies” (2024)
5. StatPearls (NCBI Bookshelf) – “Physical Activity and Weight Loss Maintenance,” National Weight Control Registry data
6. Advances in Nutrition (PMC) – “Is the Response of Human Energy Expenditure to Increased Physical Activity Additive or Constrained?” on the constrained-energy model